featured
Evolocumab Reduces Cardiovascular Events in Patients With Metabolic Syndrome Receiving Statin Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Cardiology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of PCSK9 Inhibition With Evolocumab in Reducing Cardiovascular Events in Patients With Metabolic Syndrome Receiving Statin Therapy: Secondary Analysis From the FOURIER Randomized Clinical Trial
JAMA Cardiol 2020 Aug 12;[EPub Ahead of Print], P Deedwania, SA Murphy, A Scheen, J Badariene, AL Pineda, N Honarpour, AC Keech, PS Sever, TR Pedersen, MS Sabatine, RP GiuglianoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.